Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to ease burden for dementia caregivers

NCT ID NCT07251088

Symptom relief Sponsor: German Center for Neurodegenerative Diseases (DZNE) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 27, 2026 · Updated 3 times

Summary

This study tests a program where specially trained nurses work with families caring for a person with dementia. The nurses help identify and address unmet needs, and a mobile app gives caregivers direct access to experts and memory clinics. The goal is to see if this support helps keep the person with dementia at home longer and reduces the caregiver's stress and burden. The trial will involve 554 families across multiple centers in Germany.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dyadic care management with mobile health app
What this could lead to
If successful, this could provide a practical, scalable way to help families keep loved ones with dementia at home longer and reduce caregiver stress.
What could go wrong
This is a relatively early-stage trial (not yet recruiting) and relies on caregiver engagement with the app, which may vary. The intervention is complex and may not work for all families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 554 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * formal dementia diagnosis * living in their own home for the person with dementia * access to a smartphone and internet for the informal caregiver * informed consent of the participant Exclusion Criteria: * not able to provide written consent * if a legal representative is present, they may give their consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dementia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dementia Informal caregiver Nurse care coordination

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AGAPLESION Elisabethenstift

    RECRUITING

    Darmstadt, Hesse, 64287, Germany

  • AOK Niedersachsen

    ACTIVE_NOT_RECRUITING

    Hanover, Lower Sachsony, 30173, Germany

  • DZNE

    RECRUITING

    Greifswald, Mecklenburg-Vorpommern, 17487, Germany

  • Gemeinnützige Gesellschaft für Psychiatrie Reutlingen mbh

    RECRUITING

    Reutlingen, Baden-Wurttemberg, 72764, Germany

  • IKK gesund plus

    ACTIVE_NOT_RECRUITING

    Magdeburg, Saxony, 39124, Germany

  • Institut für Technik der Informationsverarbeitung

    ACTIVE_NOT_RECRUITING

    Karlsruhe, Baden-Wurttemberg, 76131, Germany

  • Otto-von-Guericke-Universität Magdeburg

    ACTIVE_NOT_RECRUITING

    Magdeburg, Saxony, 39120, Germany

  • Universität Konstanz

    ACTIVE_NOT_RECRUITING

    Konstanz, Baden-Wurttemberg, 78464, Germany

  • Universität zu Köln

    RECRUITING

    Cologne, North Rhine-Westphalia, 50937, Germany

  • Universitätsmedizin Greifswald

    ACTIVE_NOT_RECRUITING

    Greifswald, Mecklenburg-Vorpommern, 17475, Germany

  • Universitätsmedizin Göttingen

    RECRUITING

    Göttingen, Lower Saxony, 37075, Germany

  • Universitätsmedizin Rostock

    RECRUITING

    Rostock, Mecklenburg-Vorpommern, 18057, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.